Geron
GERN
#6387
Rank
$0.92 B
Marketcap
$1.44
Share price
-1.03%
Change (1 day)
7.89%
Change (1 year)

Geron (GERN) - Net assets

Net assets on the balance sheet as of March 2026 : $0.22 Billion USD

According to Geron's latest financial reports the company has $0.22 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Geron - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$$0.22 B-19.42%
2024-12-31$$0.28 B13.06%
2023-12-31$$0.24 B209.94%
2022-12-31$$79.99 M-36.72%
2021-12-31$$0.12 B-40.07%
2020-12-31$$0.21 B56.08%
2019-12-31$$0.13 B-23.96%
2018-12-31$$0.17 B71.23%
2017-12-31$$0.10 B-15.18%
2016-12-31$$0.12 B-13.89%
2015-12-31$$0.14 B8.73%
2014-12-31$$0.13 B118.74%
2013-12-31$$59.75 M-30.23%
2012-12-31$$85.65 M-41.57%
2011-12-31$$0.14 B-23.94%
2010-12-31$$0.19 B11.68%
2009-12-31$$0.17 B2.45%
2008-12-31$$0.16 B-18.1%
2007-12-31$$0.20 B18.26%
2006-12-31$$0.17 B-1.01%
2005-12-31$$0.17 B43.94%
2004-12-31$$0.12 B14.8%
2003-12-31$$0.10 B257.5%
2002-12-31$$29.74 M-51.67%
2001-12-31$$61.54 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
$23.43 B 10,127.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
$5.62 B 2,354.24%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-$25.35 Million-111.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$2.08 B 810.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$6.85 M-97.01%๐Ÿ‡บ๐Ÿ‡ธ USA